What products are included in the Cut Mix 150 Cutting Cycle Kit?

The kit includes 3 vials of Cut Mix 150 at 150mg/ml (30ml total) and 1 pack of 100 Clomid tablets.

Does the supplied volume cover the full eight-week protocol?

Yes, but narrowly. An every-other-day cadence across eight weeks produces roughly 28 administrations, consuming about 28ml of the 30ml supplied. That leaves only around 2ml of headroom after accounting for draw-up losses and vial dead-space, so confirm injection volumes against your own records before starting.

Why does this blend use short esters instead of long ones?

Short esters such as propionate and acetate release quickly and clear between administrations, which gives researchers tighter temporal resolution around a defined observation window. Long-ester formats retain weeks-long tails that obscure day-to-day concentration changes.

How do I verify that each item in the kit is authentic?

Enter every lot number and security code on the Product Verification page at officialgenezapharma.com/product-verification/ to confirm each unit matches a genuine Dragon Pharma production run before beginning your study.

Are these compounds approved for human use?

No. This bundle sells strictly for laboratory and preclinical research. These items are not intended for human or veterinary administration and are not approved for athletic or performance purposes.

Buy Cut Mix 150 Cutting Cycle Kit Dragon Pharma | 8-Week Stack

Cut Mix 150 Cutting Cycle Kit by Dragon Pharma – Multi-Ester Blend With Recovery Material

Cutting-phase investigations usually demand frequent administration rather than weekly dosing, because short-interval schedules keep trough values tight across several ester lengths simultaneously. The Cut Mix 150 Cutting Cycle Kit accommodates that pattern by packaging a three-agent low-dose blend with the recovery material needed to close a gonadotropin-suppression study. Dragon Pharma supplies three vials of Cut Mix 150 and one pack of Clomid, quantities matched to the published schedule below. Because this format combines three distinct esterified bases in a single solution, attribution of individual effects requires careful endpoint separation; consequently, sourcing from a supplier that publishes lot-level documentation protects both your budget and your data integrity. Before ordering, review our About Us page to understand how we source, manufacture, and ship every compound in this bundle.

What Is Included in the Kit?

This bundle contains two distinct research products, quantified so supply aligns with the full protocol window without mid-cycle reorder delays:

Cut Mix 150 — 3 vials, 10 ml each at 150 mg/ml combined esters (4,500 mg / 30 ml total).
Clomid — 1 pack of 100 tablets for the recovery phase.

Investigators comparing individual components before committing to the bundle can browse each product separately on our home page.

Compound Profile

Cut Mix 150 suspends three esterified agents together in one oil solution at a combined 150 mg per millilitre: testosterone propionate, trenbolone acetate, and boldenone acetate. Formulators pair these three bases deliberately, since all carry comparatively short esters that release quickly and clear between administrations. That pharmacokinetic profile distinguishes this blend from long-ester formats, whose weeks-long tails obscure day-to-day concentration changes. Laboratories typically select such combinations when studies require tight temporal resolution around a defined observation window, rather than sustained exposure over many weeks. The modest 150 mg/ml concentration also permits fine volumetric adjustment, which matters when technicians need incremental changes across successive draws.

Clomid contains clomiphene citrate, a triphenylethylene selective estrogen receptor modulator widely used as the recovery agent in suppression protocols because it stimulates gonadotropin release.

Cycle Protocol Reference Table

The quantities above correspond directly to the following schedule. Please treat these figures as documentation of the supplied amounts, not as administration instructions.

Phase	Duration	Compound	Protocol
Cycle	Weeks 1–8	Cut Mix 150	1 mL every other day
PCT	After Cycle	Clomid	Begin post cycle therapy as directed

How the Quantities Map to the Schedule

An every-other-day cadence across eight weeks produces roughly 28 administrations, which consumes about 28 ml against the 30 ml supplied. That leaves approximately two millilitres of headroom — a thin margin once you account for draw-up losses and dead-space remaining in each vial. Investigators should therefore confirm injection volumes against their own records before starting, since even small overdraws can create a shortage late in the window. Meanwhile, the Clomid allocation supports the recovery block described above, with tablet counts sufficient for loading days, maintenance days, and any documentation-driven adjustments. Verifying these calculations against your own records prevents mid-protocol shortages.

Handling and Injection-Schedule Guidance

Qualified personnel develop all handling procedures based on species, route, and experimental endpoint. Typically, technicians warm oil-based vials between the hands before drawing, since viscosity increases storage-related resistance. Short-ester blends like this one respond well to alternate-day scheduling, which maintains reasonable trough values while avoiding excessive handling frequency. Note also that three separate containers simplify rotation: technicians can finish one vial completely before opening the next, reducing the number of punctured stoppers exposed to air. Oral units should stay sealed in their original blister packaging until use, with humidity control protecting tablet integrity. Once prepared, document each calculation step in your lab notebook so colleagues can reproduce results exactly under identical conditions.

Verifying Authenticity Before You Run Your Study

Counterfeit compounds damage experiments and waste funding. Therefore, verification should rank among your very first actions upon delivery. Every Dragon Pharma product carries security features that you can cross-check against our database in seconds. Simply enter each lot number on the Product Verification page, and the system confirms whether your units match genuine production runs. Additionally, compare printed certificate-of-analysis values against internal QC thresholds. Should any discrepancy appear, contact us immediately rather than proceeding with the study.

Storage, Shipping, and Handling

Unopened vials stay stable at controlled room temperature, away from direct light and moisture, while tablet packs require the same dry conditions. During transit, we dispatch orders in protective packaging that shields glass from crushing and blisters from heat exposure. Usually, processing completes within one business day, and tracking information follows by email. However, regulations differ between regions; consequently, review your local import rules for investigational compounds before checkout. Transparency here prevents delays and keeps your project moving on schedule.

Important Research-Use Statement

These products serve strictly laboratory and preclinical investigation. They are not FDA-approved medicines for the uses described here, and they do not intend human or veterinary administration. Furthermore, testosterone, trenbolone, and boldenone preparations appear on prohibited-substance lists maintained by major athletic authorities. Qualified personnel should handle all procedures under appropriate institutional protocols and safety equipment.

Order With Confidence

Your procurement team deserves a partner combining traceable sourcing, responsive support, and rigorous documentation across every item in a multi-component stack. To place an order, request pricing, or ask protocol-support questions about the Cut Mix 150 Cutting Cycle Kit, reach our specialists through the Contact page, and we will reply promptly with stock availability and lot information. Launch your next endocrinology study with material you can trust.